A recent study, as reported in the San Francisco Chronicle, patients who take the widely prescribed AIDS drug abacavir run nearly double the risk of heart attack compared with those who take other antiviral medications. The study was conducted in United States, Europe, and Australia.
At the moment the Food and Drug Administration (FDA) of the United States is investigating this issue, and does not have any advisor regarding the use of this drug.
The rport is available here.
Comments: